A citation-based method for searching scientific literature

Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
Times Cited: 97



M C King, S Wieand, K Hale, M Lee, T Walsh, K Owens, J Tait, L Ford, B K Dunn, J Costantino, L Wickerham, N Wolmark, B Fisher. JAMA 2001
Times Cited: 504




List of shared articles



Times cited




Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
494


The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
Lynn C Hartmann, Noralane M Lindor. N Engl J Med 2016
149

Local approaches to hereditary breast cancer.
B T Cooper, J O Murphy, V Sacchini, S C Formenti. Ann Oncol 2013
4

New insights into breast cancer genetics and impact on patient management.
Diana S Rosman, Virginia Kaklamani, Boris Pasche. Curr Treat Options Oncol 2007
15

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.
Mohamed Salhab, Selina Bismohun, Kefah Mokbel. BMC Womens Health 2010
42

Management of hereditary breast and ovarian cancer.
Hideko Yamauchi, Junko Takei. Int J Clin Oncol 2018
11

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
437

Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
Tamar Perri, Gabriel Levin, Shani Naor-Revel, Perry Eliassi-Revivo, Dror Lifshitz, Eitan Friedman, Jacob Korach. Int J Gynaecol Obstet 2021
0


Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
154

Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer.
Jennifer T Loud, Ellen Burke Beckjord, Kathryn Nichols, June Peters, Ruthann Giusti, Mark H Greene. BMC Womens Health 2009
8

Online tool to guide decisions for BRCA1/2 mutation carriers.
Allison W Kurian, Diego F Munoz, Peter Rust, Elizabeth A Schackmann, Michael Smith, Lauren Clarke, Meredith A Mills, Sylvia K Plevritis. J Clin Oncol 2012
57

Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
Sarah Fuller, Fabienne Liebens, Birgit Carly, Anne Pastijn, Serge Rozenberg. Breast J 2008
4

A comprehensive approach to the identification and management of the BRCA patient.
Christine Garcia, C Bethan Powell. Obstet Gynecol Surv 2015
3

Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?
Jennifer T Loud, Anne C M ThiĆ©baut, Andrea D Abati, Armando C Filie, Kathryn Nichols, David Danforth, Ruthann Giusti, Sheila A Prindiville, Mark H Greene. Cancer Epidemiol Biomarkers Prev 2009
21

Cancer risk assessment for the primary care physician.
Larissa A Korde, Shahinaz M Gadalla. Prim Care 2009
3

Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence.
Ciara Conduit, Roger L Milne, Michael L Friedlander, Kelly-Anne Phillips. Cancer Prev Res (Phila) 2021
1

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Dimitrios H Roukos, Evangelos Briasoulis. Nat Clin Pract Oncol 2007
90

Clinical management of hereditary breast cancer syndromes.
Amy S Clark, Susan M Domchek. J Mammary Gland Biol Neoplasia 2011
30

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.
P Shah, M Rosen, J Stopfer, J Siegfried, R Kaltman, B Mason, K Armstrong, K L Nathanson, M Schnall, S M Domchek. Breast Cancer Res Treat 2009
22

The prevention of hereditary breast cancer.
Estelamari Rodriquez, Susan M Domchek. Semin Oncol 2007
6

Development and evaluation of a decision aid for BRCA carriers with breast cancer.
Julie O Culver, Deborah J MacDonald, Andrea A Thornton, Sharon R Sand, Marcia Grant, Deborah J Bowen, Harry Burke, Nellie Garcia, Kelly A Metcalfe, Jeffrey N Weitzel. J Genet Couns 2011
20

The clinical management of BRCA1 and BRCA2 mutation carriers.
Anthony P Gulati, Susan M Domchek. Curr Oncol Rep 2008
11

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Anne Uyei, Susan K Peterson, Julie Erlichman, Kristine Broglio, Sandra Yekell, Kathkeen Schmeler, Karen Lu, Funda Meric-Bernstam, Chris Amos, Louise Strong,[...]. Cancer 2006
47

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
355